BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325]
URL: https://www.wjgnet.com/1949-8462/full/v13/i8/325.htm
Number Citing Articles
1
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, Zhijun Zhang. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal RemediesCells 2024; 13(17): 1471 doi: 10.3390/cells13171471
2
Samah S. Abbas, Mona F. Schaalan, Sahar M. Gebril, Fatma E. Hassan, Maha O. Mahmoud, Soha O. Hassanin. LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13/ACE2, miR-200, and down-regulation of TGF-β/SMAD 2/3 and miR-192Life Sciences 2022; 306: 120850 doi: 10.1016/j.lfs.2022.120850
3
Xiaoye Li, Chengchun Zuo, Can Chen, Dan Tian, Jing Li, Linlin Fan, Xiaoyu Li, Qianzhou Lv. Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort studyInternational Journal of Cardiology 2023; 371: 244 doi: 10.1016/j.ijcard.2022.09.050
4
Navya Sakhamuri, Sreekartthik Athiyaman, Bhawna Randhi, Sai Dheeraj Gutlapalli, Jingxiong Pu, Maheen F Zaidi, Maithily Patel, Lakshmi Malvika Atluri, Natalie A Gonzalez, Michael Alfonso. Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?Cureus 2023;  doi: 10.7759/cureus.37335